Seletracetam
| 150px | |
| 150px | |
| Seletracetam
| |
| Systematic (IUPAC) name | |
| (2S)-2-[(4R)-4-(2,2-difluoroethenyl) -2-oxo-pyrrolidin-1-yl]butanamide | |
| Identifiers | |
| CAS number | ? |
| ATC code | ? |
| PubChem | |
| Chemical data | |
| Formula | C10H14F2N2O |
| Mol. mass | 232.227 |
| SMILES | & |
| Pharmacokinetic data | |
| Bioavailability | >90% |
| Metabolism | ? |
| Half life | 8h |
| Excretion | ? |
| Therapeutic considerations | |
| Pregnancy cat. |
? |
| Legal status |
Unscheduled (US) |
| Routes | Oral |
Seletracetam is a drug of the racetam family. It is currently being developed by UCB Pharmaceuticals as an anticonvulsant drug. While similar in structure to so-called nootropic drugs, it is not expected to have cognitive enhancing properties.
See also
Racetams |
|---|
| Aniracetam • Brivaracetam • Coluracetam • Etiracetam/Levetiracetam • Fasoracetam • Nebracetam • Nefiracetam • Oxiracetam • Phenylpiracetam • Piracetam • Pramiracetam • Rolipram • Rolziracetam • Seletracetam |
 | This anticonvulsant-related article is a stub. You can help Wikipedia by expanding it. |
Navigation WikiDoc | WikiPatient | Popular pages | Recently Edited Pages | Recently Added
Pictures
There is no pharmaceutical or device industry support for this site and we need your viewer supported Donations | Editorial Board | Governance | Licensing | Disclaimers | Avoid Plagiarism | Policies
Table of Contents In Alphabetical Order | By Individual Diseases | Signs and Symptoms | Physical Examination | Lab Tests | Drugs
Editor Tools Become an Editor | Editors Help Menu | Create a Page | Edit a Page | Upload a Picture or File | Printable version | Permanent link | Maintain Pages | What Pages Link HereThere is no pharmaceutical or device industry support for this site and we need your viewer supported Donations | Editorial Board | Governance | Licensing | Disclaimers | Avoid Plagiarism | Policies
